Delivery Order SPE2DB20D1109-SPE2DB22FN77T
Award Date 3/10/22
Potential Completion Date 3/11/22
Potential Value $3.2K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $7,050.76 firm-fixed-price contract is for the supply of Restasis 0.05% eye emulsion under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 between the DLA Troop Support Medical and Cencora, Inc. The IDC serves as the primary vehicle for Cencora, Inc. to deliver a comprehensive range of pharmaceutical products and...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $2,647.92 firm-fixed-price delivery order is for the supply of Restasis 0.05% eye emulsion, a specialty pharmaceutical product. The contract has an ultimate completion date of January 14, 2022 and was awarded on January 13, 2022. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a subsidiary of Cencora, Inc. The $14,105.18 firm fixed-price contract is for the delivery of RESTASIS 0.05% eye emulsion, a prescription eye medication. The contract has an ultimate completion date of September 19, 2023. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $7,952.61 delivery order contract is for the supply of Restasis 0.05% eye emulsion, a prescription medication used to treat dry eye disease. The award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Cencora, Inc. holds with the DLA Troop Support Medical. This single-award IDC serves as the...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc. The contract is for the provision of Restasis 0.05% eye emulsion, a specialty pharmaceutical product, with a ceiling value of $1,620.54 and a period of performance through March 15, 2024. The delivery order is issued under an indefinite delivery contract (IDC) held by AmerisourceBergen Drug Corp, which serves as the primary...
- This federal contract award, valued at $19,805.21, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is for the delivery of Restasis 0.05% eye emulsion, a pharmaceutical product used in the treatment of dry eye disease. The contract is a delivery order under Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a ceiling value of...
- This federal contract award is for a delivery order placed by the Defense Logistics Agency (DLA) with Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,211.75, is for the delivery of Restasis 0.05% eye emulsion 60 count. This award is part of a broader Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical, valued at up to $999,999,999.00 and...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,268.24 delivery order is for the supply of RESTASIS 0.05% eye emulsion, a specialty medication used in the treatment of dry eye disease. The contract has a firm fixed price pricing type and an ultimate completion date of January 23, 2023. The award is part of a larger Indefinite Delivery Contract (IDC) held by...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Restasis 0.05% eye emulsion, a prescription medication used to treat dry eye disease. The contract has a ceiling value of $2,860.07 and a period of performance through May 8, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen...
- This is a delivery order under a larger Indefinite Delivery Contract (IDC) awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,474.50 firm fixed-price contract is for the supply of Restasis 0.05% eye emulsion. The overall IDC with Amerisourcebergen Drug Corp is valued at up to $999,999,999.00 and runs through November 2026, providing a comprehensive range of pharmaceutical products and medical supplies to...